Rankings
▼
Calendar
BCRX Q3 2016 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
Gross Profit
$8M
98.2% margin
Operating Income
-$9M
-119.0% margin
Net Income
-$12M
-148.5% margin
EPS (Diluted)
$-0.16
QoQ Revenue Growth
+62.2%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$92M
Total Liabilities
$88M
Stockholders' Equity
$4M
Cash & Equivalents
$35M
← FY 2016
All Quarters
Q4 2016 →
